CoreCivic (CXW) Earnings Date & Reports

Key Takeaways

• CoreCivic reported third-quarter 2026 revenue of $744.1 million, up 28.2% year over year and above the roughly $705.8 million consensus estimate.
• Adjusted earnings per share (EPS) of $0.49 beat analyst expectations of $0.43 by about 14%.
• Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) reached $117.8 million, topping the $109.3 million estimate.
• Normalized funds from operations (FFO), a measure of operating cash generation, rose to $0.75 per diluted share from $0.48 in the prior-year quarter.
• Management raised its full-year 2026 adjusted EPS guidance to a midpoint of $1.77, helped by stronger demand and a reduced share count.
• For additional context, explore CoreCivic's Major News, Today's Price Move, Price Targets, and Forecast on dedicated pages.
• Discover actionable, AI-driven trade ideas by exploring Trending AI Robots.

Earnings Context and Why It Matters

CoreCivic's results matter because the company sits at the intersection of federal immigration enforcement policy and private corrections infrastructure. Its revenue mix has shifted sharply toward U.S. Immigration and Customs Enforcement (ICE), which has driven rapid occupancy gains and reactivation of previously idle facilities. The third quarter also captured the completion of four major facility sales to the U.S. government, a move that reshaped the balance sheet and meaningfully reduced the share count. For investors, this report offers a read on detention demand trends, per-diem pricing, facility economics, and how management is deploying a large influx of cash.

Reported Results

CoreCivic posted third-quarter 2026 revenue of $744.1 million, an increase of 28.2% from the year-ago period, exceeding the consensus estimate near $705.8 million. Adjusted EPS came in at $0.49, above the $0.43 analysts had projected. Adjusted EBITDA reached $117.8 million, ahead of the $109.3 million consensus figure.

Normalized FFO, which strips out special items, was $69.9 million, or $0.75 per diluted share, compared with $52.1 million, or $0.48 per diluted share, a year earlier. The quarter also reflected the completion of four facility sales to the U.S. government, with gross proceeds of about $2.2 billion and net proceeds of roughly $1.6 billion. Management raised full-year 2026 adjusted EPS guidance to a midpoint of $1.77 and set adjusted EBITDA guidance near a $444 million midpoint.

AI Screener

Tickeron's AI Screener is an AI-powered stock and exchange-traded fund (ETF) discovery tool designed to help traders and investors filter the market using technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs with customizable filters covering industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps surface trade ideas, trending stocks, and breakout candidates more efficiently than manual screening. Explore the AI Screener to see how it can support your research process.

Market Reaction and Investor Sentiment

CoreCivic entered the quarter with investor attention focused on ICE detention volumes, which had dipped in early 2026 before rebounding. The company's ability to beat revenue and adjusted EPS expectations, while raising full-year guidance, signals that demand and pricing held up better than the market anticipated. The completed facility sales and the associated accelerated share repurchase (ASR) also reframed the investment story around capital returns and a leaner share base, factors that tend to support per-share metrics even as management flags that sold facilities will now operate under modified management contracts.

Forward Outlook and Key Factors to Monitor

Looking ahead, the most important variable remains ICE detention demand and occupancy levels across CoreCivic's reactivated facilities. The company has indicated it expects to begin receiving detainees at the newly awarded Appleton Facility in the fourth quarter of 2026, with full activation targeted for the second quarter of 2027. Investors will watch whether occupancy at recently activated sites such as California City and Diamondback continues to climb.

A second area to monitor is the transition of the four sold facilities to government ownership. CoreCivic expects to continue managing these sites, but the terms of those contracts may change, and the contracts carry termination provisions tied to government funding. These dynamics could weigh on future revenue and margin comparisons.

Finally, capital deployment remains a key theme. The company launched a $500 million accelerated share repurchase and still holds a sizable authorized repurchase capacity. How management balances buybacks, the integration of the recently acquired Clinical Solutions Pharmacy business, and potential additional government facility acquisitions will shape the outlook for adjusted EPS and FFO over the coming quarters.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations